Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **microtubule polymerization machinery** refers to the collection of proteins and molecular complexes that regulate the assembly and disassembly ("polymerization dynamics") of microtubules within eukaryotic cells. Microtubules are long, hollow cylinders composed primarily of α/β-tubulin heterodimers that assemble into linear protofilaments; these protofilaments then associate laterally to form a cylindrical tube[1][4][7]. The dynamic behavior—growth, shrinkage, pausing—of microtubules is essential for their biological functions in cell division, intracellular transport, cell shape maintenance, and more[6][7]. Key protein factors involved in this machinery include XMAP215 family members (such as Msps/chTOG), EB1 proteins, CLASP proteins, kinesin family members like kinesin‑13 Klp10A/Sentin in Drosophila models—and regulatory kinases such as Plk1 Polo[2][3]. These factors collectively control the nucleation at specific sites via γ-tubulin complexes[5], elongation by adding tubulin dimers at the plus end[1], catastrophe events leading to rapid shrinkage[2], rescue events returning shrinking filaments back to growth phase[2], and overall spatial-temporal organization. This target is considered "incorrect" for structured drug discovery purposes because it does not refer to a single molecule or gene product but rather an entire multi-component system. However, individual components within this system—such as β-tubulin or specific regulatory enzymes—are well-established therapeutic targets. Drugs like paclitaxel stabilize assembled microtubules against depolymerization while others like vincristine/vinblastine disrupt normal dynamics by inhibiting tubulin polymerization; both mechanisms are exploited clinically in cancer therapy due to their ability to block mitosis by interfering with spindle formation. In summary: "Microtubule polymerization machinery" describes a critical cellular apparatus comprising multiple interacting proteins responsible for building and remodeling the cytoskeleton's microtubes—a process fundamental for cell proliferation and targeted by several major classes of anticancer drugs. It is not itself a single canonical drug target but rather an umbrella term encompassing several validated molecular targets within its network.[1][2][3]
Stabilization of microtubules (e.g., paclitaxel binds and stabilizes microtubules to prevent depolymerization) - Inhibition of polymerization or promotion of depolymerization (e.g., vinca alkaloids bind tubulin dimers and inhibit assembly or promote disassembly)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule polymerization machinery.